Budde LE, Assouline S, Sehn LH, Schuster SJ, et al. Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. J Clin Oncol 2024;42:2250-2256.
PMID: 38547425